BG

Bharat Garg

Active Director Director DIN 10215229
DIN 10215229 First appointment Jun 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Bharat Garg

Data last updated:

Bharat Garg is a Director at Nishkarshan Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Nishkarshan Pharmaceuticals Private Limited reported revenue of ₹13.2 Lakh (FY 2025).

DIN 10215229
Primary Designation Director
Industry Paper
First Appointment 26 Jun 2023
Oldest Company Age 3 yrs
Largest company Nishkarshan Pharmaceuticals Private Limited · ₹13.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jun 20232023₹13.2 Lakh (FY 2025)Active

Board colleagues of Bharat Garg

Directorship timeline

Open interactive timeline →
Nishkarshan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bharat Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharat Garg

Bharat Garg currently holds 1 directorship: Nishkarshan Pharmaceuticals Private Limited (Director, since 26 Jun 2023, revenue ₹13.2 Lakh (FY 2025)).

Bharat Garg was first appointed on 26 Jun 2023 as Director at Nishkarshan Pharmaceuticals Private Limited.

The current boards of Bharat Garg's companies include Mukesh Gupta (Nishkarshan Pharmaceuticals Private Limited), Nandinee Gupta (Nishkarshan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available